Virax Biolabs Group Limit...
(VRAX)
undefined
undefined%
At close: undefined
2.97
-6.31%
Pre-market Jan 07, 2025, 05:49 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 |
| Net Income | -6.74M | -5.46M | -1.71M | -650.98K | -739.46K |
| Depreciation & Amortization | 103.10K | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | 1.01M | 1.73M | 290.36K | n/a | n/a |
| Other Working Capital | -269.56K | -237.23K | 2.19K | 0.00 | n/a |
| Other Non-Cash Items | 497.06K | -260.60K | -32.07K | 1.19K | 91.67K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -1.12M | -216.28K | 644.39K | 59.61K | -96.82K |
| Operating Cash Flow | -6.25M | -4.18M | -809.07K | -590.19K | -744.61K |
| Capital Expenditures | -1.16M | -178.40K | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -211.95K | -178.40K | n/a | n/a | n/a |
| Investing Cash Flow | -1.16M | -178.40K | n/a | n/a | n/a |
| Debt Repayment | -206.27K | 146.25K | 100.00K | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 1.85M | -111.64K | 193.59K | 585.20K | 704.64K |
| Financial Cash Flow | 1.65M | 13.69M | 813.21K | 585.20K | 704.64K |
| Net Cash Flow | -5.76M | 9.33M | 4.13K | -4.99K | -39.97K |
| Free Cash Flow | -7.41M | -4.36M | -809.07K | -590.19K | -744.61K |